| Item Type | Name |
|
Academic Article
|
Common estrogen receptor polymorphism augments effects of hormone replacement therapy on E-selectin but not C-reactive protein.
|
|
Academic Article
|
Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).
|
|
Academic Article
|
Effect of estrogen plus progestin on progression of carotid atherosclerosis in postmenopausal women with heart disease: HERS B-mode substudy.
|
|
Academic Article
|
Effects of estrogens and selective estrogen receptor modulators on indicators of cardiovascular health in postmenopausal women.
|
|
Academic Article
|
Randomized clinical trials of hormone replacement therapy for treatment or prevention of cardiovascular disease: a review of the findings.
|
|
Academic Article
|
ER-alpha variants and the cardiovascular effects of hormone replacement therapy.
|
|
Academic Article
|
Pulse pressure and coronary atherosclerosis progression in postmenopausal women.
|
|
Academic Article
|
Impaired fasting glucose and cardiovascular outcomes in postmenopausal women with coronary artery disease.
|
|
Academic Article
|
Randomized trial of hormone therapy in women after coronary bypass surgery. Evidence of differential effect of hormone therapy on angiographic progression of disease in saphenous vein grafts and native coronary arteries.
|
|
Academic Article
|
Effect of genetic variations in platelet glycoproteins Ibalpha and VI on the risk for coronary heart disease events in postmenopausal women taking hormone therapy.
|
|
Academic Article
|
Interleukin-10 concentration and coronary heart disease (CHD) event risk in the estrogen replacement and atherosclerosis (ERA) study.
|
|
Academic Article
|
Plasma levels of HDL subpopulations and remnant lipoproteins predict the extent of angiographically-defined coronary artery disease in postmenopausal women.
|
|
Academic Article
|
Effects of hormone therapy on soluble cell adhesion molecules in postmenopausal women with coronary artery disease.
|
|
Academic Article
|
Adherence to 2005 Dietary Guidelines for Americans is associated with a reduced progression of coronary artery atherosclerosis in women with established coronary artery disease.
|
|
Academic Article
|
Association of polymorphisms in genes involved in lipoprotein metabolism with plasma concentrations of remnant lipoproteins and HDL subpopulations before and after hormone therapy in postmenopausal women.
|
|
Academic Article
|
Subgroup interactions in the Heart and Estrogen/Progestin Replacement Study: lessons learned.
|
|
Academic Article
|
Estrogen-receptor polymorphisms and effects of estrogen replacement on high-density lipoprotein cholesterol in women with coronary disease.
|
|
Academic Article
|
Statin therapy, cardiovascular events, and total mortality in the Heart and Estrogen/Progestin Replacement Study (HERS).
|
|
Academic Article
|
Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/progestin Replacement Study. A randomized, double-blind, placebo-controlled trial.
|
|
Academic Article
|
From presumed benefit to potential harm--hormone therapy and heart disease.
|
|
Academic Article
|
Effects of conjugated oestrogen and droloxifene on the renin-angiotensin system, blood pressure and renal blood flow in postmenopausal women.
|
|
Academic Article
|
Fish intake is associated with a reduced progression of coronary artery atherosclerosis in postmenopausal women with coronary artery disease.
|
|
Academic Article
|
Racial differences in endothelial function in postmenopausal women.
|
|
Academic Article
|
Dietary fats, carbohydrate, and progression of coronary atherosclerosis in postmenopausal women.
|
|
Academic Article
|
The effects of hormone therapy on the markers of inflammation and endothelial function and plasma matrix metalloproteinase-9 level in postmenopausal women: the postmenopausal estrogen progestin intervention (PEPI) trial.
|
|
Academic Article
|
Cereal fiber and whole-grain intake are associated with reduced progression of coronary-artery atherosclerosis in postmenopausal women with coronary artery disease.
|
|
Academic Article
|
Diabetes, the metabolic syndrome, and angiographic progression of coronary arterial disease in postmenopausal women.
|
|
Academic Article
|
Progestins affect mechanism of estrogen-induced C-reactive protein stimulation.
|
|
Academic Article
|
Effects of conjugated equine estrogen on stroke in the Women's Health Initiative.
|
|
Academic Article
|
Effects of estrogen replacement with and without medroxyprogesterone acetate on brachial flow-mediated vasodilator responses in postmenopausal women with coronary artery disease.
|
|
Academic Article
|
Changes in remnant and high-density lipoproteins associated with hormone therapy and progression of coronary artery disease in postmenopausal women.
|
|
Academic Article
|
Submaximal exercise coronary artery flow increases in postmenopausal women without coronary artery disease after estrogen and atorvastatin.
|
|
Academic Article
|
Effect of hormone replacement therapy on plasma lipoprotein levels and coronary atherosclerosis progression in postmenopausal women according to type 2 diabetes mellitus status.
|
|
Concept
|
Postmenopause
|
|
Academic Article
|
Dietary macronutrients, genetic variation, and progression of coronary atherosclerosis among women.
|
|
Academic Article
|
Plasma alkylresorcinols, biomarkers of whole-grain intake, are not associated with progression of coronary artery atherosclerosis in postmenopausal women with coronary artery disease.
|
|
Academic Article
|
Endogenous Sex Hormones and Endothelial Function in Postmenopausal Women and Men: The Multi-Ethnic Study of Atherosclerosis.
|